Voss; Matthew E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Voss; Matthew E..The latest application filed is for "2,6,7 substituted purines as hdm2 inhibitors".

Company Profile

0.21.26

Voss; Matthew E. - Singapore SG
Voss; Matthew E. - Ville De West SG
VOSS; Matthew E. - Arlington NJ SG
Voss; Matthew E. - Nassau NY
Voss; Matthew E. - Lincoln Univ. PA
Voss; Matthew E. - Lincoln University PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2,6,7 substituted purines as HDM2 inhibitors Grant 9,682,978 - Christopher , et al. June 20, 2	2017-06-20
Substituted pyrrolopyrimidines as HDM2 inhibitors Grant 9,637,493 - Dinsmore , et al. May 2, 2	2017-05-02
2,6,7,8 substituted purines as HDM2 inhibitors Grant 9,540,377 - Cammarano , et al. January 10, 2	2017-01-10
2,6,7 Substituted Purines As Hdm2 Inhibitors App 20150368247 - Christopher; Matthew P. ; et al.	2015-12-24
2,6,7,8 Substituted Purines As Hdm2 Inhibitors App 20150353553 - Cammarano; Carolyn Michele ; et al.	2015-12-10
Substituted Pyrrolopyrimidines As Hdm2 Inhibitors App 20150329548 - Dinsmore; Christopher ; et al.	2015-11-19
Substituted piperidines as HDM2 inhibitors Grant 9,062,071 - Ma , et al. June 23, 2	2015-06-23
Substituted imidazopyridines as HDM2 inhibitors Grant 8,962,611 - Christopher , et al. February 24, 2	2015-02-24
Substituted Imidazopyridines As Hdm2 Inhibitors App 20140357618 - Christopher; Matthew P. ; et al.	2014-12-04
Vinca derivatives Grant 8,895,543 - Scott , et al. November 25, 2	2014-11-25
SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF App 20140336222 - Bogen; Stephane L. ; et al.	2014-11-13
Substituted Piperidines As Hdm2 Inhibitors App 20140323482 - Ma; Yao ; et al.	2014-10-30
Substituted imidazopyridines as HDM2 inhibitors Grant 8,846,657 - Christopher , et al. September 30, 2	2014-09-30
Substituted Imidazopyridines as HDM2 Inhibitors App 20140179680 - Christopher; Matthew P. ; et al.	2014-06-26
Certain substituted ureas, as modulators of kinase activity Grant 8,222,421 - Mitchell , et al. July 17, 2	2012-07-17
Vinorelbine derivatives Grant 8,053,428 - Scott , et al. November 8, 2	2011-11-08
Vinorelbine derivatives Grant 7,842,802 - Scott , et al. November 30, 2	2010-11-30
Certain Substituted Ureas, As Modulators Of Kinase Activity App 20100286190 - Mitchell; Scott A. ; et al.	2010-11-11
Certain substituted ureas, as modulators of kinase activity Grant 7,777,040 - Mitchell , et al. August 17, 2	2010-08-17
Vinca derivatives Grant 7,745,619 - Scott , et al. June 29, 2	2010-06-29
Vinorelbine Derivatives App 20090088568 - Scott; Ian L. ; et al.	2009-04-02
Vinca Derivatives App 20080108644 - SCOTT; Ian L. ; et al.	2008-05-08
Lactams as modulators of chemokine receptor activity Grant 7,338,975 - Carter , et al. March 4, 2	2008-03-04
Vinorelbine Derivatives App 20080051425 - SCOTT; Ian L. ; et al.	2008-02-28
Vinca Derivatives App 20070179171 - Scott; Ian L. ; et al.	2007-08-02
Vinorelbine Derivatives App 20070179170 - SCOTT; Ian L. ; et al.	2007-08-02
Vinca derivatives Grant 7,238,704 - Scott , et al. July 3, 2	2007-07-03
Vinorelbine derivatives Grant 7,235,564 - Scott , et al. June 26, 2	2007-06-26
Certain substituted ureas, as modulators of kinase activity App 20060270702 - Mitchell; Scott A. ; et al.	2006-11-30
Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. Grant 6,984,648 - Lu , et al. January 10, 2	2006-01-10
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE) Grant 6,962,938 - Ott , et al. November 8, 2	2005-11-08
Vinorelbine derivatives App 20050176748 - Scott, Ian L. ; et al.	2005-08-11
Vinca derivatives App 20050137169 - Scott, Ian L. ; et al.	2005-06-23
Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE) Grant 6,884,806 - Decicco , et al. April 26, 2	2005-04-26
Lactams as modulators of chemokine receptor activity App 20040186143 - Carter, Percy H. ; et al.	2004-09-23
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha App 20040162426 - Lu, Zhonghui ; et al.	2004-08-19
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) App 20040132693 - Ott, Gregory R. ; et al.	2004-07-08
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE) Grant 6,720,329 - Ott , et al. April 13, 2	2004-04-13
Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) App 20030181438 - Decicco, Carl P. ; et al.	2003-09-25
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) App 20030087882 - Ott, Gregory R. ; et al.	2003-05-08
Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors App 20030073682 - Voss, Matthew E. ; et al.	2003-04-17
.beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. Grant 6,495,565 - Duan , et al. December 17, 2	2002-12-17
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha App 20020016336 - Duan, Jingwu ; et al.	2002-02-07
Beta-Amino-Acid derivatives as inhibitors of matrix metalloproteases and TNF-Alpha App 20020013341 - Duan, Jingwu ; et al.	2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.